79135-52-7

Basic information

• Product Name: 1,2-bis(4-isopropylphenyl)acetylene
• Synonyms: 1,2-bis(4-isopropylphenyl)acetylene
• CAS NO: 79135-52-7
• Molecular Weight: 262.395
• Mol File: 79135-52-7.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: 1,2-bis(4-isopropylphenyl)acetylene(CAS DataBase Reference)
• NIST Chemistry Reference: 1,2-bis(4-isopropylphenyl)acetylene(79135-52-7)
• EPA Substance Registry System: 1,2-bis(4-isopropylphenyl)acetylene(79135-52-7)

Safety Data

• Hazardous Substances Data: 79135-52-7(Hazardous Substances Data)

Upstream product

• 82234-68-2 p-dichloromethylcumene 
• 586-61-8 4-iso-propylbromobenzene 
• 1010840-17-1 1,2-bis(4’,4’,5’,5’-tetramethyl[1’,3’,2’]dioxaborolan-2’-yl)ethyne 
• 23152-99-0 p-ethynylcumene 
• 54290-22-1 α,α-dimethylbenzyl iodide 
• 384850-37-7 1-(4-isopropylphenyl)-2-trimethylsilylacetylene 
• 17356-09-1 4-iodocumene 
• 74-86-2 acetylene 
• 79152-62-8 C₂₀H₂₆N₄ 
• 79135-55-0 1,2-Dichloro-1,2-bis(p-isopropylphenyl)ethane 

Downstream Products

• 37163-82-9 (E)-1,2-bis(4-isopropylphenyl)ethene 
• 81734-58-9 4,4'-diisopropyl-cis-stilbene 

Relevant articles and documents

Rh(iii)-Catalyzed three-component cascade annulation to produce theN-oxopropyl chain of isoquinolone derivatives

Developing powerful methods to introduce versatile functional groups at theN-substituents of isoquinolone scaffolds is still a great challenge. Herein, we report a novel three-component cascade annulation reaction to efficiently construct theN-oxopropyl chain of isoquinolone derivativesviarhodium(iii)-catalyzed C-H activation/cyclization/nucleophilic attack, with oxazoles used both as the directing group and potential functionalized reagents.

Calcium carbide catalytically activated with tetra-: N -butyl ammonium fluoride for Sonogashira cross coupling reactions

We report a novel method for the direct synthesis of mono- and bis-arylated alkynes utilizing catalytically activated CaC2 as the alkyne component. This fluoride-activated cross coupling reaction provides advantages over existing methods regarding operational simplicity, use of readily available starting materials, and low cost.

5,6,7-Trisubstituted 4-Aminopyrido[2,3-d]pyrimidines as Novel Inhibitors of Adenosine Kinase

The synthesis and structure-activity relationship of a series of 5,6,7-trisubstituted 4-aminopyrido[2,3-d]pyrimidines as novel nonnucleoside adenosine kinase inhibitors is described. A variety of alkyl, aryl, and heteroaryl substituents were found to be tolerated at the C5, C6, and C7 positions of the pyridopyrimidine core. These studies have led to the identification of analogues that are potent inhibitors of adenosine kinase with in vivo analgesic activity.